Cargando…
Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
Hypertrophic cardiomyopathy (HCM) is a primary disorder of contractility in heart muscle. To gain mechanistic insight and guide pharmacological rescue, this study models HCM using isogenic pairs of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying the E99K-ACTC1 cardiac...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235010/ https://www.ncbi.nlm.nih.gov/pubmed/30392975 http://dx.doi.org/10.1016/j.stemcr.2018.10.006 |
_version_ | 1783370813077979136 |
---|---|
author | Smith, James G.W. Owen, Thomas Bhagwan, Jamie R. Mosqueira, Diogo Scott, Elizabeth Mannhardt, Ingra Patel, Asha Barriales-Villa, Roberto Monserrat, Lorenzo Hansen, Arne Eschenhagen, Thomas Harding, Sian E. Marston, Steve Denning, Chris |
author_facet | Smith, James G.W. Owen, Thomas Bhagwan, Jamie R. Mosqueira, Diogo Scott, Elizabeth Mannhardt, Ingra Patel, Asha Barriales-Villa, Roberto Monserrat, Lorenzo Hansen, Arne Eschenhagen, Thomas Harding, Sian E. Marston, Steve Denning, Chris |
author_sort | Smith, James G.W. |
collection | PubMed |
description | Hypertrophic cardiomyopathy (HCM) is a primary disorder of contractility in heart muscle. To gain mechanistic insight and guide pharmacological rescue, this study models HCM using isogenic pairs of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying the E99K-ACTC1 cardiac actin mutation. In both 3D engineered heart tissues and 2D monolayers, arrhythmogenesis was evident in all E99K-ACTC1 hiPSC-CMs. Aberrant phenotypes were most common in hiPSC-CMs produced from the heterozygote father. Unexpectedly, pathological phenotypes were less evident in E99K-expressing hiPSC-CMs from the two sons. Mechanistic insight from Ca(2+) handling expression studies prompted pharmacological rescue experiments, wherein dual dantroline/ranolazine treatment was most effective. Our data are consistent with E99K mutant protein being a central cause of HCM but the three-way interaction between the primary genetic lesion, background (epi)genetics, and donor patient age may influence the pathogenic phenotype. This illustrates the value of isogenic hiPSC-CMs in genotype-phenotype correlations. |
format | Online Article Text |
id | pubmed-6235010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-62350102018-11-19 Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits Smith, James G.W. Owen, Thomas Bhagwan, Jamie R. Mosqueira, Diogo Scott, Elizabeth Mannhardt, Ingra Patel, Asha Barriales-Villa, Roberto Monserrat, Lorenzo Hansen, Arne Eschenhagen, Thomas Harding, Sian E. Marston, Steve Denning, Chris Stem Cell Reports Article Hypertrophic cardiomyopathy (HCM) is a primary disorder of contractility in heart muscle. To gain mechanistic insight and guide pharmacological rescue, this study models HCM using isogenic pairs of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying the E99K-ACTC1 cardiac actin mutation. In both 3D engineered heart tissues and 2D monolayers, arrhythmogenesis was evident in all E99K-ACTC1 hiPSC-CMs. Aberrant phenotypes were most common in hiPSC-CMs produced from the heterozygote father. Unexpectedly, pathological phenotypes were less evident in E99K-expressing hiPSC-CMs from the two sons. Mechanistic insight from Ca(2+) handling expression studies prompted pharmacological rescue experiments, wherein dual dantroline/ranolazine treatment was most effective. Our data are consistent with E99K mutant protein being a central cause of HCM but the three-way interaction between the primary genetic lesion, background (epi)genetics, and donor patient age may influence the pathogenic phenotype. This illustrates the value of isogenic hiPSC-CMs in genotype-phenotype correlations. Elsevier 2018-11-01 /pmc/articles/PMC6235010/ /pubmed/30392975 http://dx.doi.org/10.1016/j.stemcr.2018.10.006 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Smith, James G.W. Owen, Thomas Bhagwan, Jamie R. Mosqueira, Diogo Scott, Elizabeth Mannhardt, Ingra Patel, Asha Barriales-Villa, Roberto Monserrat, Lorenzo Hansen, Arne Eschenhagen, Thomas Harding, Sian E. Marston, Steve Denning, Chris Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title | Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title_full | Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title_fullStr | Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title_full_unstemmed | Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title_short | Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits |
title_sort | isogenic pairs of hipsc-cms with hypertrophic cardiomyopathy/lvnc-associated actc1 e99k mutation unveil differential functional deficits |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235010/ https://www.ncbi.nlm.nih.gov/pubmed/30392975 http://dx.doi.org/10.1016/j.stemcr.2018.10.006 |
work_keys_str_mv | AT smithjamesgw isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT owenthomas isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT bhagwanjamier isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT mosqueiradiogo isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT scottelizabeth isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT mannhardtingra isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT patelasha isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT barrialesvillaroberto isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT monserratlorenzo isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT hansenarne isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT eschenhagenthomas isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT hardingsiane isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT marstonsteve isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits AT denningchris isogenicpairsofhipsccmswithhypertrophiccardiomyopathylvncassociatedactc1e99kmutationunveildifferentialfunctionaldeficits |